Assistant Professor of Internal Medicine, Department of Translational Medicine, University of Ferrara, Italy. Assistant Adjunct Professor University of Alberta (Canada). Co-leader for the McGill coordination center of the GOING-FWD (https://www.mcgill.ca/going-fwd4gender/) Project. Co-Chair of the IMAGINE (Internal Medicine and Assessment of Gender differences in Europe) Working Group of the EFIM. Over the past 5 years, her principal research interests have focused on understanding sex and gender-specific issues in cardiovascular disease. She was the PI on a 5-year grant entitled “Sex and gender differences in ischemic heart disease: from bench to bedside - Endocrine Vascular Disease Approach (EVA),” at Sapienza University of Rome, Italy, funded by the Scientific Independence of Young Researchers (SIR) Program, promoted by the Italian Ministry of Education, University and Research (MIUR) (2015-2020). She was awarded the Elizabeth Young Investigator Award from the Organization for the Study of Sex Differences (OSSD) in Atlanta, U.S.A. Her current work is aimed at establishing a transatlantic network of experts in gender medicine, internal medicine specialists, and outcomes researchers (GOING-FWD Consortium). This collaboration aims to identify appropriate measures of gender which can be feasibly applied to evaluate chronic noncommunicable diseases. From March 2020, she is part of the COVID-19 Mortality Group of the Italian National Institute of Health (ISS) (https://www.epicentro.iss.it/en/coronavirus/sars-cov-2-analysis-of-deaths) and she is an Italian researcher partner of the iCARE Study (https://mbmc-cmcm.ca/covid19/).

Rita F. Redberg, MD, MSc, is a cardiologist and Professor of Medicine at the University of California, San Francisco since 1990 and Core Faculty, Philip R Lee Institute for Health Policy Studies. Dr. Redberg is the Chief Editor of JAMA Internal Medicine since 2009 and has spearheaded the journal’s new focus on health care reform and “less is more”. Her research interests are in the area of health policy and technology assessment, and how to promote high value care, focusing on high risk medical devices as well as the need for inclusion of women in clinical trials of such devices. Dr. Redberg recently completed a 6 year term on the Medicare Payment Advisory Commission, which advises Congress on Medicare payment issues. She also served on the Medicare Evidence, Development and Coverage Advisory Committee from 2003-2006 and was reappointed as its Chairwoman from 2012 - 2016. She has given Congressional testimony multiple times in hearings related to the issue of balancing safety and innovation in medical device approvals. Dr. Redberg worked in the office of Senator Hatch and with the Senate Judiciary Committee on FDA-related matters during her tenure as a Robert Wood Johnson Health Policy Fellow, 2003-2006. Dr. Redberg is a member of the National Academy of Medicine.

- Internal Medicine specialist, Ph.D. by the University of Barcelona in 2013 and Master in Health Management at the UIC-Barcelona University. - Clinical Chief of the Internal Medicine Department at Hospital Universitari de Bellvitge (Barcelona). - Head of the Systemic Diseases and Ageing Research Group from the Bellvitge Biomedical Research Institute (IDIBELL). - Associate Professor, Faculty of Medicine and Health Sciences from the Universitat de Barcelona. - Author of more than 100 artices indexed in PubMed in the field of rare diseases and venous thromboembolism. - Clinical and research expertise in rare diseases: - Spanish Coordinator of the Rare Diseases Working Group from the Spanish Society of Internal Medicine (SEMI) - Coordinator of the national registry called RiHHTa (Computerized Registry of the Hemorrhagic Hereditary Telangiectasia) - Awarded in 2017 and 2020 with two national Spanish grants to go further in genetic and therapeutic knowledge about HHT and other rare vascular diseases - Director of three dissertations (Ph.D.) in Hemorrhagic Hereditary Telangiectasia.